|
Real-time Estimate
Cboe Europe
12:20:00 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 53.40 CHF | +0.19% |
|
+4.09% | -49.14% |
| 10-21 | Cosmo N.V. - Special Call | |
| 10-19 | Cosmo Pharmaceuticals N.V. Reports Positive Phase 2 Study Results Of Rifamycin 1% Topically Acting Gel In Distal Ulcerative Colitis And Ulcerative Proctitis | CI |
| Market Cap | 992M 1.11B 916M 830M 1.55B 105B 1.58B 11.03B 4.37B 55.24B 4.17B 4.08B 174B | P/E 2026 * |
858x | P/E 2027 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise Value | 969M 1.09B 895M 811M 1.52B 103B 1.54B 10.77B 4.27B 53.97B 4.07B 3.99B 170B | EV / Sales 2026 * |
9.12x | EV / Sales 2027 * | 5.61x |
| Free-Float |
40.52% | Yield 2026 * |
3.68% | Yield 2027 * | 3.91% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| COPN | Delayed | |
CBOE
| 0RGI | Real-time | |
|
Tradegate
| C43 | Real-time | |
|
London S.E.
| 0RGI | Delayed | |
|
Boerse Muenchen
| C43 | Real-time | |
|
OTC Markets
| CMOPF | Delayed | |
|
Deutsche Boerse AG
| C43 | Delayed | |
|
Xetra
| C43 | Delayed | |
|
Börse Stuttgart
| C43 | Delayed | |
|
Wiener Boerse
| COPN | End-of-day quote |
Last Transcript: Cosmo N.V.
| 1 day | +0.38% | ||
| 1 week | +4.09% | ||
| Current month | -3.08% | ||
| 1 month | -0.93% | ||
| 3 months | -14.81% | ||
| 6 months | -41.53% | ||
| Current year | -49.14% |
| 1 week | 51.3 |  | 54.3 |
| 1 month | 49 | | 57 |
| Current year | 49 | | 129.4 |
| 1 year | 49 | | 129.4 |
| 3 years | 33.7 | | 129.4 |
| 5 years | 33.7 | | 129.4 |
| 10 years | 33.7 | | 188.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 2024-05-23 | |
| Director of Finance/CFO | - | 2024-11-10 | |
Paolo Lanzarotti
CTO | Chief Tech/Sci/R&D Officer | 53 | 2008-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mauro Ajani
CHM | Chairman | 71 | 2013-12-31 |
| Director/Board Member | 71 | 2012-03-31 | |
Niall Donnelly
BRD | Director/Board Member | 54 | 2024-05-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/11/26 | Sell | -30,000 | 0.1710% | |||
| 4/22/26 | Sell | 4,000 | 0.0228% | |||
| 4/21/26 | Sell | 10,500 | 0.0599% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.19% | +4.09% | -21.21% | +58.05% | 1.11B | |
| +0.43% | +3.35% | +55.11% | +125.64% | 1,135B | |
| +0.54% | +4.76% | +39.71% | +78.43% | 635B | |
| +0.13% | +1.43% | +25.73% | +97.46% | 505B | |
| +1.43% | +4.31% | +48.28% | +67.12% | 378B | |
| -2.93% | -1.27% | +61.14% | +34.34% | 358B | |
| -0.27% | +2.80% | +23.77% | +50.05% | 295B | |
| +0.25% | +3.71% | +2.50% | +23.75% | 266B | |
| +0.35% | +3.89% | +51.62% | +63.68% | 237B | |
| +1.57% | +3.89% | +32.00% | +102.57% | 193B | |
| Average | +0.17% | +1.71% | +31.86% | +70.11% | 400.48B | |
| Weighted average by Cap. | +0.16% | +1.63% | +41.71% | +83.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 106M 119M 98.2M 88.99M 166M 11.3B 169M 1.18B 468M 5.92B 447M 437M 18.66B | 176M 197M 163M 147M 276M 18.71B 280M 1.96B 775M 9.8B 740M 724M 30.91B |
| Net income | 1.27M 1.43M 1.18M 1.07M 2M 135M 2.03M 14.17M 5.61M 70.99M 5.36M 5.24M 224M | 47.65M 53.36M 44.02M 39.89M 74.63M 5.07B 75.87M 530M 210M 2.65B 200M 196M 8.37B |
| Net Debt | -22.75M -25.48M -21.02M -19.05M -35.63M -2.42B -36.22M -253M -100M -1.27B -95.61M -93.58M -3.99B | -3.7M -4.14M -3.42M -3.1M -5.8M -393M -5.89M -41.13M -16.28M -206M -15.55M -15.22M -650M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-26 | CHF 53.50 | +0.38% | 16,033 |
| 26-10-23 | CHF 53.30 | +1.33% | 36,650 |
| 26-10-22 | CHF 52.60 | -1.13% | 27,163 |
| 26-10-21 | CHF 53.20 | +0.57% | 31,676 |
| 26-10-20 | CHF 52.90 | +2.92% | 62,162 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COPN Stock
Select your edition
All financial news and data tailored to specific country editions
